White & Case has advised Karo Pharma AB on the deal.Karo Pharma AB executed its fully underwritten SEK 2.5 billion (approximately US$260 million) rights issue. The…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
